These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 8528563

  • 1. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
    Ko FN, Yu SM, Kang YF, Teng CM.
    Br J Pharmacol; 1995 Sep; 116(2):1801-8. PubMed ID: 8528563
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW, Becker MW, Davis MG.
    J Biol Chem; 1992 Dec 05; 267(34):24897-905. PubMed ID: 1447225
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 05; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 5. Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits.
    Pfister SL, Kotulock DA, Campbell WB.
    Hypertension; 1997 Jan 05; 29(1 Pt 2):303-9. PubMed ID: 9039119
    [Abstract] [Full Text] [Related]

  • 6. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    Yu SM, Ko FN, Wu TS, Lee JY, Teng CM.
    Eur J Pharmacol; 1994 Apr 11; 256(1):85-91. PubMed ID: 8026563
    [Abstract] [Full Text] [Related]

  • 7. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 11; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

  • 8. Thromboxane A2 and vascular smooth muscle cell proliferation.
    Sachinidis A, Flesch M, Ko Y, Schrör K, Böhm M, Düsing R, Vetter H.
    Hypertension; 1995 Nov 11; 26(5):771-80. PubMed ID: 7591017
    [Abstract] [Full Text] [Related]

  • 9. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
    Hanasaki K, Nakano K, Kasai H, Arita H, Ohtani K, Doteuchi M.
    Biochem Biophys Res Commun; 1988 Feb 15; 150(3):1170-5. PubMed ID: 2963633
    [Abstract] [Full Text] [Related]

  • 10. Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats.
    Ko FN.
    Arterioscler Thromb Vasc Biol; 1997 Jul 15; 17(7):1274-82. PubMed ID: 9261257
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH, Woodward DF, Burk RM, Gac TS, Gibson LL, Protzman CE, Abbass F, Marshall K, Senior J.
    J Ocul Pharmacol Ther; 1997 Aug 15; 13(4):303-12. PubMed ID: 9261766
    [Abstract] [Full Text] [Related]

  • 12. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-beta.
    Craven PA, Studer RK, DeRubertis FR.
    Hypertension; 1996 Aug 15; 28(2):169-76. PubMed ID: 8707377
    [Abstract] [Full Text] [Related]

  • 13. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells.
    Hanasaki K, Nakano T, Arita H.
    Biochem Pharmacol; 1990 Dec 01; 40(11):2535-42. PubMed ID: 2148480
    [Abstract] [Full Text] [Related]

  • 14. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
    Matsuda K, Mathur RS, Duzic E, Halushka PV.
    Am J Physiol; 1993 Dec 01; 265(6 Pt 1):E928-34. PubMed ID: 8279549
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
    Fukunaga M, Yura T, Grygorczyk R, Badr KF.
    Am J Physiol; 1997 Apr 01; 272(4 Pt 2):F477-83. PubMed ID: 9140048
    [Abstract] [Full Text] [Related]

  • 16. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
    Jones DA, Benjamin CW, Linseman DA.
    Mol Pharmacol; 1995 Nov 01; 48(5):890-6. PubMed ID: 7476920
    [Abstract] [Full Text] [Related]

  • 17. Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
    Yura T, Fukunaga M, Grygorczyk R, Makita N, Takahashi K, Badr KF.
    Adv Prostaglandin Thromboxane Leukot Res; 1995 Nov 01; 23():237-9. PubMed ID: 7732843
    [No Abstract] [Full Text] [Related]

  • 18. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 19. Amplifying interactions between spasmogens in vascular smooth muscle.
    MacLennan SJ, Bolofo ML, Martin GR.
    Biochem Soc Trans; 1993 Nov 01; 21(4):1145-50. PubMed ID: 8131914
    [No Abstract] [Full Text] [Related]

  • 20. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
    Dorn GW, Becker MW.
    J Pharmacol Exp Ther; 1993 Apr 01; 265(1):447-56. PubMed ID: 8474027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.